Glenmark Life Sciences, subsidiary of Glenmark Pharmaceuticals has filed the red herring prospectus with the Registrar of Companies on 19 July 2021. The details of the proposed initial public offer are under:
Fresh issue - up to Rs 1060 crore
Offer by sale by Glenmark Pharmaceuticals - up to 63 lakh equity shares
Anchor investor bid/ offer period - 26 July 2021
Bid/ offer opening date - 27 July 2021
Bid/ offer closing date - 29 July 2021
Expected date of listing - 06 August 2021
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
